Clinical Trial Update: Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041) [NA]

View source ↗

Summary

This completed Merck Sharp & Dohme-sponsored clinical trial (NCT00211601) evaluated chemotherapy and patient health outcomes for chemotherapy-induced nausea and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chemotherapy Induced Nausea and Vomiting | NA | Status: COMPLETED